Harry is a NIHR Academic Clinical Lecturer in Neurology. He completed his medical training and DPhil in Clinical Neurosciences in Oxford, before moving to Bristol to undertake his Neurology training in 2015. He took up his current position in July 2017.
Harry’s research aims to develop biomarkers that allow the diagnosis of Parkinson’s disease in its earliest stages, before the onset of motor symptoms. Neurodegeneration in the substantia nigra starts many years before motor symptoms emerge and the final diagnosis of Parkinson’s can be made. Identification of patients in the early, prodromal, stage would provide insight into the earliest pathological pathways and open the door to the targeted use of novel neuroprotective agents.
DPhil in Clinical Neurosciences, 2017
University of Oxford
MRCP (Lond.), 2011
Royal College of Physicians London
BM BCh, 2008
University of Oxford
BA Medical Sciences, 2005
University of Oxford